Relation Therapeutics
-
The Crucial Role of Biological Data in AI Drug Discovery
GSK is expanding its AI-driven drug discovery efforts through a significant collaboration with Relation Therapeutics. This partnership leverages Relation’s expertise in generating high-volume, sophisticated human cell datasets. These datasets will train advanced AI models, including Relation’s MORGAN platform, to rapidly pinpoint novel drug targets. Building on prior successful collaborations, this agreement integrates cutting-edge data generation with AI model development for more precise therapeutic discovery.
